Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes

Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

(2015) Morten A. Karsdal et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop

(2015) Arun J. Sanyal et al.   HEPATOLOGY

Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension

(2015) D. J. Leeming et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

COL6A3expression in adipocytes associates with insulin resistance and depends on PPARγ and adipocyte size

(2014) Simon N. Dankel et al.   Obesity

Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction

(2014) Kai Sun et al.   Nature Communications

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours

(2013) Jiyoung Park et al.   EMBO Molecular Medicine

Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?

(2013) Jiyoung Park et al.   Expert Review of Anticancer Therapy

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study

(2012) Lauren N. Bell et al.   HEPATOLOGY

Adipocyte-derived endotrophin promotes malignant tumor progression

(2012) Jiyoung Park et al.   JOURNAL OF CLINICAL INVESTIGATION

Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist

(2012) R. Agrawal et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats

(2011) M. Feigh et al.   DIABETES OBESITY & METABOLISM

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

(2011) Kim Henriksen et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis – Identification and Validation of a Novel Biochemical Marker Assay

(2011) Sanne Skovgård Veidal et al.   PLoS One

Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)

(2010) Bernard Charbonnel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adipose Tissue Collagen VI in Obesity

(2009) Magdalena Pasarica et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study

(2009) Ian J. Douglas et al.   PLOS MEDICINE

Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress

(2008) Nobuo Cho et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

New Drugs for Type 2 Diabetes Mellitus

(2008) Andrew J Krentz et al.   DRUGS

Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone

(2008) Philip J. Larsen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance

(2008) A.K. Lampe et al.   HUMAN MUTATION

Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI

(2008) T. Khan et al.   MOLECULAR AND CELLULAR BIOLOGY

The effect of thiazolidinediones on BMD and osteoporosis

(2008) Allyson K McDonough et al.   Nature clinical practice. Endocrinology & metabolism